SARS-CoV-2, Influenza and Other Respiratory Viruses: Epidemiology, Burden of Disease, and Preventive Measures

Dear Colleagues,

Respiratory viruses are among the most frequent causative agents of disease in humans, with substantial impact on morbidity and mortality worldwide. However, little is known about the real burden of disease of many infections caused by respiratory viruses. Moreover, since the onset of the COVID-19 pandemic, most countries have reported historically low circulation, and whether viruses such as influenza and RSV will have a usual circulation in the future is still uncertain. Finally, the current pandemic has greatly accelerated advances in preventive measure research, especially vaccines, vaccine production, and vaccination strategies.

This Special Issue of Vaccines on “SARS-CoV-2, Influenza, and Other Respiratory Viruses: Epidemiology, Burden of Disease, and Preventive Measures” aims to achieve a more extensive understanding of recent scientific knowledge and current trends around the epidemiology, the burden of disease, and the preventive measures of SARS-CoV-2, influenza, and other respiratory viruses. Research and review papers, as well as viewpoints, are welcome.

You may choose our Joint Special Issue in Vaccines.

Dr. Marco Del Riccio
Dr. William John Paget
Dr. Saverio Caini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• respiratory
• viruses
• SARS-CoV-2
• human influenza
• respiratory syncytial virus
• vaccines
• vaccination strategies
• epidemiology
• burden of disease